Temasek Holdings
OMIC

Temasek Holdings’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Temasek Holdings’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-714
Closed -$53.5K – 80
2022
Q3 		$53.5K Hold
714
– – ﹤0.01% 81
2022
Q2 		$81.8K Hold
714
– – ﹤0.01% 96
2022
Q1 		$135K Hold
714
– – ﹤0.01% 96
2021
Q4 		$247K Buy
+714
New +$277K ﹤0.01% 94

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Temasek Holdings's OMIC Position: Q4 2022 in Review

Temasek Holdings sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2022, closing a stake of 714 shares — an estimated $53.5K sold.

Temasek Holdings first reported a position in OMIC in Q4 2021 and held it in 4 quarters. The position peaked at $247K in Q4 2021. 80 funds tracked by Wall St. Rank hold OMIC as of Q4 2022.

  • Temasek Holdings reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Temasek Holdings sold 714 Singular Genomics Systems, Inc. Common Stock shares in Q4 2022, an estimated $53.5K.
  • Temasek Holdings first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Temasek Holdings's Singular Genomics Systems, Inc. Common Stock position peaked at $247K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2022.

Based on Temasek Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.